For: | Hou GM, Liu HL, Wu H, Zeng Y. Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages. Ann Surg Oncol 2021. [PMID: 33900502 DOI: 10.1245/s10434-021-09949-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Hou GM, Zeng Y. ASO Author Reflections: Tumor Marker Score Based on Conventional Tumor Markers (AFP, CEA, and CA19-9) Predicts Prognosis Well for cHCC-CC Patients After Surgery. Ann Surg Oncol 2021. [PMID: 33895901 DOI: 10.1245/s10434-021-09983-z] [Reference Citation Analysis] |
2 | Hou GM, Jiang C, Du JP, Yuan KF. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Cancer Med 2021. [PMID: 34866356 DOI: 10.1002/cam4.4448] [Reference Citation Analysis] |